Strategies to facilitate smooth product rollout and transition
Smooth product rollout and transition requires programs to plan ahead and develop tools and mechanisms, such as product memos which describe the key features of products and how they should be used, job aides, such as wall chart algorithms to decide if a patient is eligible for a new product, and trainings, to ensure effective uptake of new products. It is also critical that new products are integrated into existing systems for ordering and reporting, and patient information systems.
Facility-Level Implementation Checklist
Develop national rollout plans that define activities for phase-in and monitoring of product introduction, with clear timelines, and roles and responsibilities across Ministry of Health (MoH) and partners
Develop and implement product introduction tools, including product memos, job aides, patient information guides
Update stock monitoring tools (e.g. CHAI National Stock Status Dashboard), ordering forms, and patient management systems to include new products
Develop a comprehensive rollout plan (e.g. CHAI Product Rollout Planning Template) that clearly defines targets, timelines and roles and responsibilities across stakeholders
Disseminate and implement the rollout plan working with key stakeholders at the national, regional, and facility levels
Educate health care providers, patients, and civil society about the benefits and characteristics of new products so that they can better understand their treatment
Incorporate supervision of appropriate prescribing and use of the new product within ongoing training and mentorship activities at facilities
Use the links below to download the entire HIV New Product Introduction Guide
or the Facility-Level Implementation chapter only
Facility-Level Implementation Tools and Resources
The tools and resources below are intended to support the management and coordination of product phase-in as rollout activities take place at the facility level. Facility level rollout should be implemented in accordance with the national rollout strategy and plan developed during the national rollout planning exercise. Facility-level rollout can be time and labour intensive, and coordinated activities and messaging across MoH, implementing partners, community advocates and other stakeholders is critical to successful implementation.
Featured Resources: CHAI Product Rollout Planning Template
The CHAI Product Rollout Planning Template is designed to provide a skeleton for MoHs and implementing partners to map out and document the key activities, milestones, and timelines required to implement product introduction plans. The tool is designed as a template for MoHs to add the relevant activities and milestones for their context; however, some key steps and milestones are included for consideration.
Training personnel on the guidelines for use, clinical characteristics and monitoring requirements for use of new drugs is extremely important to ensure correct prescribing and ensure key information on new products is accurately understood and retained. Key groups to train include policy makers, physicians, nurses, pharmacists/logisticians, laboratory technicians, social workers, community health workers, expert patients, and opinion and community leaders:
Resources for countries rolling out DTG and TLD:
Resources for Sexual and Reproductive Health Integration
Resources for countries integrating HIV and sexual and reproductive health (SRH) services and family planning (FP):
LPV/r Oral Pellets & Granules Resources:
Pediatric Optimization Resources:
Resources for rolling out Atazanavir/Ritonavir (ATV/r)
HIV i-Base is a treatment activist group based in London, UK. The organization is committed to providing timely and up to date information about HIV treatment to HIV-positive individuals and to health care professionals. This includes technical and non-technical publications (all also available online, many in other languages) and a Q&A service (by phone, email and online). All resources are produced by and with the involvement of HIV positive people and are reviewed by a medical advisory group, and can be made available for adaption to support the needs of local rollout and training, on request: